Large gap with delayed quotes
Analysis date: 24.07.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 10.02.2026.
Interest
Strong
Strong
Three stars since 14.07.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.07.2026 at a price of 296.86.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 26.06.2026.
4wk Rel Perf
15.70%
15.70%
The four-week dividend-adjusted overperformance versus SP500 is 15.70%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.02.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.49%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.35%.
Mkt Cap in $bn
8.47
8.47
With a market capitalization >$8bn, BIO-RAD LABORATORIES is considered a large-cap stock.
G/PE Ratio
0.65
0.65
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
29.33
29.33
The estimated PE is for the year 2028.
LT Growth
19.05%
19.05%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
3
3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
51
51
For 1% of index variation, the stock varies on average by 0.51%.
Correlation
0.15
0.15
Stock movements are totally independent of index variations.
Value at Risk
75.47
75.47
The value at risk is estimated at USD 75.47. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
23.10.2018
23.10.2018